Skip to content

Oncology

Pretreatment Patient Evaluation and Transfusion Risk Assessment

Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses. (opens new window)

Abu-Ghanem Y, Dotan Z, Kaver I, Ramon J.

Source‎: J Surg Oncol 2015;112(5):496-502.

Indexed‎: PubMed 26437866

DOI‎: 10.1002/jso.24029

https://www.ncbi.nlm.nih.gov/pubmed/26437866 (opens new window)

Drug interactions with phytotherapeutics in oncology. (opens new window)

Haefeli WE, Carls A.

Source‎: Expert Opin Drug Metab Toxicol 2014;10(3):359-77.

Indexed‎: PubMed 24387348

DOI‎: 10.1517/17425255.2014.873786

https://www.ncbi.nlm.nih.gov/pubmed/24387348 (opens new window)

Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation. (opens new window)

Kekre N, Christou G, Mallick R, Tokessy M, Tinmouth A, Tay J, Allan DS.

Source‎: Transfusion 2012;52(9):2049-54.

Indexed‎: PubMed 22321053

DOI‎: 10.1111/j.1537-2995.2011.03552.x

https://www.ncbi.nlm.nih.gov/pubmed/22321053 (opens new window)

Clinical factors affecting engraftment and transfusion needs in SCT: a single-center retrospective analysis. (opens new window)

Liesveld J, Pawlowski J, Chen R, Hyrien O, Debolt J, Becker M, Phillips G 2nd, Chen Y.

Source‎: Bone Marrow Transplant 2013;48(5):691-7.

Indexed‎: PubMed 23085827

DOI‎: 10.1038/bmt.2012.194

https://www.ncbi.nlm.nih.gov/pubmed/23085827 (opens new window)

Trends and risk factors for transfusion in hepatopancreatobiliary surgery. (opens new window)

Lucas DJ, Schexneider KI, Weiss M, Wolfgang CL, Frank SM, Hirose K, Ahuja N, Makary M, Cameron JL, Pawlik TM.

Source‎: J Gastrointest Surg 2014;18(4):719-28.

Indexed‎: PubMed 24323432

DOI‎: 10.1007/s11605-013-2417-9

https://www.ncbi.nlm.nih.gov/pubmed/24323432 (opens new window)

Potential interactions with anticancer agents: a cross-sectional study. (opens new window)

Mouzon A, Kerger J, D'Hondt L, Spinewine A.

Source‎: Chemotherapy 2013;59(2):85-92.

Indexed‎: PubMed 23881290

DOI‎: 10.1159/000351133

https://www.ncbi.nlm.nih.gov/pubmed/23881290 (opens new window)

ONCOLOGY
Pretreatment Patient Evaluation and Transfusion Risk Assessment
English
Pretreatment Patient Evaluation and Transfusion Risk Assessment
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Contact

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

View Downloads

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

View Videos